학술논문
A U.S. Food and Drug Administration–pooled Analysis of Frontline Combination Treatment Survival Benefits by Risk Groups in Metastatic Renal Cell Carcinoma
Document Type
Article
Author
Source
In European Urology October 2023 84(4):373-378
Subject
Language
ISSN
0302-2838